Antiphospholipid antibodies in acute coronary syndrome

Lupus

Volumn 13, Issue 6, 2004, Pages 423-427

  Veres, K ^a   Lakos, G ^a   Kerenyi A ^a   Szekanecz, Z ^a   Szegedi, G ^a   Shoenfeld, Y ^b,c   Soltész, Pál ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

2 glycoprotein I; Acute coronary syndrome; Antiphospholipid antibody; Coronary artery disease; Myocardial infarction

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN A; PHOSPHOLIPID ANTIBODY;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STROKE; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 3142672076     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1011oa     Document Type: Article

References (22)

1. Bick RL, Baker WF. Antiphospholipid syndrome and thrombosis. Semin Thromb Haemost 1999; 25; 333-350.
2. Singh AK. Immunopathogenesis of the antiphospholipid antibody syndrome: an update. Curr Opin Nephrol Hypertens, 2001; 10: 355-358.
3. Asherson RA, Khamashta MA, Ordi-Ros J et al. The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374.
4. Soltész P, Veres K, Lakos G, Kiss E, Muszbek L, Szegedi G. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients. Lupus 2003; 12: 302-307.
5. Farsi A, Domenghetti MP, Fedi S et al. High prevalence of anti-beta2-glycoprotein I antibodies in patients with ischemic heart disease. Autoimmunity 1999; 30: 93-98.
6. George J, Shoenfeld Y, Harats D. The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. J Autoimmun 1999; 13: 57-60.
7. George J, Harats D, Gilburd D et al. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation 1999; 99: 2227-2230.
8. Shoenfeld Y, Sherer Y, George J, Harats D. Autoantibodies associated with atherosclerosis. Ann Med 2000; 32(Suppl I): 37-40.
9. Sherer Y, Shemesh J, Tenenbaum A et al. Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain. Am J Cardiol 2000; 86: 1306-1311.
10. Sherer Y, Tenenbaum A, Praprotnik S et al. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I and oxidized LDL antibodies. Cardiology 2001; 95: 20-24.
11. Sherer Y, Tenenbaum A, Praprotnik S et al. Autoantibodies to cardiolipin and beta-2-glycoprotein I in coronary artery disease patients with and without hypertension. Cardiology 2002; 97: 2-5.
12. de Groot PG, Bouma B, Lutters BC, Derksen RH. Lupus anticoagulant in cardiovascular diseases: the role of beta-2-glycoprotein I. Ann Med 2000; 32(Suppl I): 32-36.
13. Vaarala O. Antiphospholipid antibodies and atherosclerosis. Lupus 1996; 5: 442-447.
14. Adler Y, Finkelstein Y, Zandeman-Goddard G et al. The presence of antiphospholipid antibodies in acute myocardial infarction. Lupus 1995; 4: 309-313.
15. Limaye V, Beltrame J, Cook R, Gillis D, Pile K. Evaluation of antibodies to beta-2-glycoprotein I in the causation of coronary atherosclerosis as part of the antiphospholipid syndrome. Aust N Z J Med 1999; 29: 789-793.
16. The Joint European Society of Cardiology/American College of Cardiology Committee: Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-1513.
17. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-1190.
18. Dunoyer-Geindre S, Kruithof EK, Galve-de-Rochemonteix B et al. Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells. Thromb Haemost 2001; 85: 903-907.
19. Harats D, George J. Beta2-glycoprotein I and atherosclerosis. Curr Opin Lipidol 2001; 12: 543-546.
20. Lakos G, Kiss E, Regéczy N et al. Isotype distribution and clinical relevance of anti-β2-glycoprotein I (β2-GPI) antibodies: importance of the IgA isotype. Clin Exp Immunol 1999; 117: 574-579.
21. Lee RM, Branch DW, Silver RM. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol 2001; 185: 748-753.
22. Fiallo P, Tomasina C, Clapasson A, Cardo PP. Antibodies to beta2-glycoprotein I in ischemic stroke. Cerebrovasc Dis 2000; 10: 293-297.